Acro Biomedical Co., Ltd. (ACBM)

CIK 1622996 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Acro Biomedical Co., Ltd..

Recent SEC filings

FiledFormAccession number
Sep 2, 20268-K0001640334-26-001447
Aug 14, 202610-Q0001640334-26-001345
May 5, 202610-Q0001640334-26-000824
Feb 11, 202610-K0001640334-26-000241
Jan 8, 20268-K0001640334-26-000053
Aug 14, 20258-K0001640334-25-001486
Aug 5, 202510-Q0001640334-25-001347
Jul 24, 202510-Q0001640334-25-001302
Jul 24, 202510-K0001640334-25-001300
Jul 23, 202510-Q0001640334-25-001279
Jul 23, 202510-Q0001640334-25-001281
Jul 22, 202510-Q0001640334-25-001257
Jul 18, 202510-K0001640334-25-001245
Jul 11, 202510-Q0001640334-25-001169
Jul 2, 20258-K0001640334-25-001097
Nov 15, 2023NT 10-Q0001640334-23-002178
Aug 14, 202310-Q0001640334-23-001563
Aug 2, 202310-Q0001640334-23-001422
Jul 21, 202310-K0001640334-23-001347
Apr 3, 2023NT 10-K0001640334-23-000544
Nov 21, 202210-Q0001640334-22-002503
Nov 14, 2022NT 10-Q0001640334-22-002449
Aug 12, 202210-Q0001640334-22-001752
May 16, 202210-Q0001640334-22-001037
Apr 15, 202210-K0001640334-22-000809